Ana holds a PhD in Biomedical Sciences from the Faculty of Medicine, University of Lisbon, Portugal. Her main contributions as a researcher were in molecular biology, parasitology and translational research. Currently, she is highly interested and working in innovation in healthcare and science communication.
Focal therapy with high-intensity focused ultrasound is effective in the medium term and rarely causes urinary or rectal side effects in patients with clinically significant localized prostate cancer, a large, ... Read more
Consumption of a low-protein diet during pregnancy and breastfeeding may increase the risk of male offspring developing prostate cancer later in life, a rat study suggests. The study, “Maternal Low-Protein Diet ... Read more
A combination of two approved immunotherapies — Opdivo (nivolumab) and Yervoy (ipilimumab) — appears to delay cancer progression and lengthen survival in a subset of patients with an aggressive form of ... Read more
Yonsa was recently approved by the U.S. Food and Drug Administration, in combination with methylprednisolone, for the treatment of metastatic castration-resistant prostate cancer. The announcement was made by Sun Pharma and Churchill ... Read more
Obesity can improve overall survival in men with late-stage, castration-resistant prostate cancer, a study showed. However, obesity does not seem to change the risk of death due to prostate ... Read more
A new approach to detecting tumor cells in the blood offers a minimally invasive alternative to identifying prostate cancer patients who may not respond to first-line treatments, Canadian researchers ... Read more
Prostate cancer patients who have disease recurrence following radical prostatectomy should undergo imaging scans using the imaging agent 68Ga-PSMA-11 to guide their salvage radiotherapy, a new study suggests. The study, ... Read more